Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Human Interest

Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
Administering two types of immunotherapy drugs concurrently has paused or reversed malignant tumor growth in almost sixty percent of patients participating in a UK clinical trial.
A recent case study from the Yale School of Medicine has found that tofacitinib, a drug frequently used to treat rheumatoid arthritis, has successfully treated a patient’s vitiligo reports CBS News. The condition is characterized by loss of pigmentation...